Clearside Biomedical Debt to Equity Ratio Insights

Clearside Biomedical Inc (CLSD)

1.03 +0.02 (+1.98%) USD | NASDAQ | Nov 04, 16:00

1.06 +0.03 (+2.91%) After-Hours: 20:00

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2016. Upgrade now.

Date	Value
June 30, 2024	0.00
March 31, 2024	0.00
December 31, 2023	0.00
September 30, 2023	0.00
June 30, 2023	0.00
March 31, 2023	0.00
December 31, 2022	0.00
September 30, 2022	0.00
June 30, 2022	0.00
March 31, 2022	0.00
December 31, 2021	0.00
September 30, 2021	0.00
June 30, 2021	0.00
March 31, 2021	0.00
December 31, 2020	0.1131
September 30, 2020	0.122
June 30, 2020	0.136

Date	Value
March 31, 2020	0.4965
December 31, 2019	0.4618
September 30, 2019	1.041
June 30, 2019	0.7828
March 31, 2019	0.6237
December 31, 2018	0.4223
September 30, 2018	0.2248
June 30, 2018	0.1477
March 31, 2018	0.085
December 31, 2017	0.374
September 30, 2017	0.2142
June 30, 2017	0.1435
March 31, 2017	0.1145
December 31, 2016	0.1059
September 30, 2016	0.1596
June 30, 2016	0.1239
March 31, 2016	1.104

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

Minimum

Mar 2021

0.4965

Maximum

Mar 2020

0.07

Average

Median